Back
Pliant Therapeutics Vs. Equifax Industry Stock Comparison
Sell
39
PLRX
Pliant Therapeutics
Last Price:
13.61
Seasonality Move:
39.12%
Buy
61
EFX
Equifax
Last Price:
229.51
Seasonality Move:
3.45%
Sell
39
Pliant Therapeutics (PLRX)
is a Sell
Is Pliant Therapeutics a Buy, Sell or Hold?
- The current Pliant Therapeutics [PLRX] share price is $13.24. The Score for PLRX is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
- PLRX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
61
Equifax (EFX)
is a Buy
Is Equifax a Buy, Sell or Hold?
- The current Equifax [EFX] share price is $224.50. The Score for EFX is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
- EFX is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
PLRX Stock Price Chart
What is Pliant Therapeutics's stock price today?
-
The Pliant Therapeutics share price today is $13.24
The current trend is relatively stagnant and PLRX is experiencing buying pressure, which is a positive indicator for future bullish movement.
PLRX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.64 | Sell |
| Relative Strength Index (14 RSI): | 49.2 | Sell |
| Chaikin Money Flow: | 146926 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (12.28 - 14.54) | Sell |
| Bollinger Bands (100): | (13.93 - 17.65) | Sell |
EFX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -9.02 | Sell |
| Relative Strength Index (14 RSI): | 37.76 | Sell |
| Chaikin Money Flow: | 417413 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (222.57 - 255.59) | Sell |
| Bollinger Bands (100): | (235.19 - 262.33) | Sell |
PLRX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 12.24 | Buy |
| 20-day SMA: | 13.1 | Buy |
| 50-day SMA: | 14.45 | Sell |
| 200-day SMA: | 15.88 | Sell |
| 8-day EMA: | 12.51 | Buy |
| 20-day EMA: | 12.99 | Buy |
| 50-day EMA: | 14.12 | Sell |
| 200-day EMA: | 16.36 | Sell |
EFX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 223.84 | Buy |
| 20-day SMA: | 234.26 | Sell |
| 50-day SMA: | 251.71 | Sell |
| 200-day SMA: | 221.63 | Buy |
| 8-day EMA: | 224.31 | Buy |
| 20-day EMA: | 232.49 | Sell |
| 50-day EMA: | 242.51 | Sell |
| 200-day EMA: | 230.53 | Sell |
Pliant Therapeutics Earnings Growth & PLRX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.07 per share, an increase next quarter of $0.02 per share, a decrease this year of $0.39 per share, and a decrease next year of $0.25 per share.
Equifax Earnings Growth & EFX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.24 per share, an increase next quarter of $0.25 per share, an increase this year of $0.73 per share, and an increase next year of $2.17 per share.
Pliant Therapeutics Technical Analysis
| Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 19 | 22 | 23 | 24 | 25 | 26 | 29 | 30 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Equifax Technical Analysis
| Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 19 | 22 | 23 | 24 | 25 | 26 | 29 | 30 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||